Hyaluronic Acid - Therapeutic use
Research News and Information

Sunday, November 22, 2009

Medial knee joint loading increases in those who respond to hyaluronan injection for medial knee osteoarthritis.

30 Oct 2009 Knee osteoarthritis (OA) is a cause of decline in function and the medial compartment is often affected. Intraarticular injection of hyaluronic acid (HA) is indicated as a symptom modifying treatment with at least 6 months passing between ... Read more...

Endothelial keratoplasty: the use of viscoelastic as an aid in reattaching the dislocated graft in abnormally structured eyes.

7 Jul 2009 PURPOSE: To explore the feasibility of reattaching the dislocated graft with viscoelastic in abnormally structured eyes after Descemet-stripping automated endothelial keratoplasty (DSAEK). DESIGN: Retrospective case series. PARTICIPANTS: Five ... Read more...

Nonsurgical management of congenital eyelid malpositions using hyaluronic Acid gel.

29 Jun 2009 PURPOSE: To report our preliminary experience using hyaluronic acid gel fillers as a nonsurgical alternative in the management of congenital eyelid malpositions. METHODS: In this retrospective interventional case series, 5 patients (10 eyes) with ... Read more...

Latest indexed articles for 'Hyaluronic Acid - Therapeutic use'

These are the very latest articles for this heading:

• Medial knee joint loading increases in those who respond to hyaluronan injection for medial knee osteoarthritis. 30 Oct 2009
• Endothelial keratoplasty: the use of viscoelastic as an aid in reattaching the dislocated graft in abnormally structured eyes. 7 Jul 2009
• Osteoarthritis: Hyaluronic acid is not effective in symptomatic hip OA. 29 Jun 2009
• Nonsurgical management of congenital eyelid malpositions using hyaluronic Acid gel. 29 Jun 2009
• A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial). 15 Jun 2009
• Use of hyaluronic acid for vaginal stenosis in a woman with a history of imperforate hymen and transverse vaginal septum: a case report. 30 May 2009
• Treatment of infrabony periodontal defects with esterified hyaluronic acid: clinical report of 19 consecutive lesions. 30 May 2009
• [The statement of Polish Gynecological Society Experts on the barrier agents for adhesion prevention after gynaecological surgery] 30 May 2009
• Soft cochlear implantation: rationale for the surgical approach. 30 May 2009
• Therapeutic targets for osteoarthritis. 4 May 2009
• Novel hyaluronic acid-methotrexate conjugates for osteoarthritis treatment. May 2009
• Reduction of postoperative abdominal adhesion and ileus by a bioresorbable membrane. 29 Apr 2009
• [What's new in aesthetic dermatology: filler and laser treatments] 29 Apr 2009
• [Periocular aging: physiopathogenesis, clinical aspect, and treatment] 29 Apr 2009
• Assessment of a new hyaluronic acid filler. double-blind, randomized, comparative study between Puragen and Captique in the treatment of nasolabial folds. 29 Apr 2009
• Clinical inquiries. Do hyaluronic acid injections relieve OA knee pain? 29 Apr 2009
• Clinical efficacy of a Ginkgo biloba extract in the topical treatment of allergic conjunctivitis. 29 Apr 2009
• Intra-articular clodronate for the treatment of knee osteoarthritis: dose ranging study vs hyaluronic acid. 28 Apr 2009
• Temporomandibular joint osteoarthritis: an open label trial of 76 patients treated with arthrocentesis plus hyaluronic acid injections. 27 Apr 2009
• The short- and long-term effects of Seprafilm on peripheral nerves: a histological and functional study. 22 Apr 2009

See a longer list of these articles.

Technical information about 'Hyaluronic Acid'

Definition: A natural high-viscosity mucopolysaccharide with alternating beta (1-3) glucuronide and beta (1-4) glucosaminidic bonds. It is found in the UMBILICAL CORD, in VITREOUS BODY and in SYNOVIAL FLUID. A high urinary level is found in PROGERIA.

Chemical name: Hyaluronic acid

Registry Number: 9004-61-9

Descriptor UI: D006820

Alternative terms: Hyaluronic Acid; Acid, Hyaluronic; Amvisc; Bausch and Lomb Brand of Sodium Hyaluronate; Biolon; Akorn, Inc. Brand of Sodium Hyaluronate; Etamucine; Hyaluronan; Hyvisc; Anika Therapeutics Brand of Sodium Hyaluronidate; Luronit; Sodium Hyaluronate; Hyaluronate, Sodium; Hyaluronate Sodium; Amo Vitrax; Vitrax, Amo; Advanced Medical Optics, Inc. Brand of Sodium Hyaluronate; Healon; Advanced Medical Optics Brand of Sodium Hyaluronidate;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists; ultrastructure;

Pharmacological Action: Viscosupplements; Adjuvants, Immunologic;

Tree Number: D09.698.373.475;

History Note: 2002; for BIOLON use POLYMETHYL METHACRYLATE 1977-2001